{"id":"W2920797638","doi":"10.1183/13993003.00164-2019","title":"Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019","year":2019,"lang":"en","type":"review","venue":"European Respiratory Journal","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":1965,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of British Columbia; McGill University Health Centre","funders":"Manchester Biomedical Research Centre; National Institutes of Health; Genentech; Grifols; Regeneron Pharmaceuticals; York University; AstraZeneca; Chiesi Farmaceutici; CSL Behring; Sunovion; Gilead Sciences; Sanofi; American Thoracic Society; Pfizer; Biogen; GlaxoSmithKline; Bundesministerium für Bildung und Forschung; National Institute for Health and Care Research; Veracyte; Teva Pharmaceutical Industries","keywords":"Medicine; Obstructive lung disease; Intensive care medicine; Pulmonary disease; Lung disease; Gold standard (test); Lung; Internal medicine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07461363120069818,"score_gpt":0.388639464185003,"score_spread":0.3140258329843048,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}